Acura Pharmaceuticals Provides Update on FDA Discussions Surrounding Development of Aversion Hydrocodone With Acetaminophen Tablet
August 15, 2014 06:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Aug 15, 2014) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR), announced today preliminary discussions from a meeting held with the U.S. Food and Drug Administration (FDA)...
Acura Pharmaceuticals Announces Second Quarter 2014 Financial Results
August 04, 2014 16:05 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Aug 4, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals to Host Second Quarter 2014 Financial Results Conference Call on August 5, 2014
July 24, 2014 16:05 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Jul 24, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company plans...
Acura Pharmaceuticals Provides Update on Its Abuse Deterrent Hydrocodone/Acetaminophen Combination Drug
May 27, 2014 17:00 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - May 27, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced the US Food and Drug Administration (FDA) advised the Company that the data from our...
Acura Pharmaceuticals Announces Settlement of Patent Litigation With Sandoz Inc.
May 21, 2014 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - May 21, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.
May 08, 2014 06:30 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - May 8, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals Announces First Quarter 2014 Financial Results
May 05, 2014 16:10 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - May 5, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals to Host First Quarter 2014 Financial Results Conference Call on May 6, 2014
April 28, 2014 15:40 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Apr 28, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company plans...
Acura Pharmaceuticals Announces Return of Product Rights
April 10, 2014 06:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Apr 10, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals to Present at the 26th Annual ROTH Conference
March 05, 2014 14:00 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Mar 5, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...